Robyn T Kiy

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 4

Top Topics

Induced Apoptosis

Quality Control

Mesenchymal Stem Cells

Top Venues

Toxicology research

British journal of pharmacology

AstraZeneca UK Ltd

University of Liverpool (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

AstraZeneca UK Ltd Jul 02 2018 - Jun 28 2019

United Kingdom

Industrial Placement student :: Dosage form design & development

Education History

University of Liverpool Oct 01 2019

United Kingdom

PHD :: Department of Pharmacology and Therapeutics

Publications

Robyn T Kiy, Saye H Khoo, Amy E Chadwick
Assessing the mitochondrial safety profile of the molnupiravir active metabolite, β-d-N4-hydroxycytidine (NHC), in the physiologically relevant HepaRG model. Toxicology research 13 (1) (2024)
Robyn T Kiy, Saye H Khoo, Amy E Chadwick
Assessing the mitochondrial safety profile of the molnupiravir active metabolite, β-d-N4-hydroxycytidine (NHC), in the physiologically relevant HepaRG model. Toxicology research 13 (1) (2024)
Sophie L Penman, Rebecca L Jensen, Robyn T Kiy, Amy E Chadwick
The mitochondrial paradox. eLife 9 (2020)
Sophie L Penman, Robyn T Kiy, Rebecca L Jensen, Christopher Beoku-Betts, Ana Alfirevic, David Back, Saye H Khoo, Andrew Owen, Munir Pirmohamed, B Kevin Park, Xiaoli Meng, Christopher E Goldring, Amy E Chadwick
Safety perspectives on presently considered drugs for the treatment of COVID-19. British journal of pharmacology 177 (19) (2020)